Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Failure of Amino-nucleoside to produce Abnormalities in the Fœtus of the Rat

Abstract

IN an experimental study of urinary tract malformations, an attempt is being made in our laboratory to influence with chemical agents the embryonic development of the kidney. One substance that has been used is the amino-nucleoside derivative of ‘Puromycin(R)’, which is known to produce increased albuminuria and the nephrotic syndrome in rats. Hallman et al.1 have used this substance in attempts to induce a congenital nephrotic syndrome in experimental animals, and they have described renal tubular dilatation in some offspring of rats treated during the last days of pregnancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hallman, N., Hjelt, L., and Kouvalalnen, K., Ann. paediat. Fenn., 6, 289 (1960).

    CAS  PubMed  Google Scholar 

  2. Smithies, O., Biochem. J., 71, 585 (1959).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BERNSTEIN, J., MEYER, R. & PICKMAN, D. Failure of Amino-nucleoside to produce Abnormalities in the Fœtus of the Rat. Nature 195, 1209 (1962). https://doi.org/10.1038/1951209a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/1951209a0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing